Early post-discharge follow-up improves lipid control and reduces cardiovascular risk in ACS patients: insights from a tertiary cardiac centre

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Amr Elkammash

Bristol Heart Institute, Bristol (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail

Predictive value of blood count derived inflammatory markers for LDL cholesterol target achievement after STEMI

Doctor V. Halatiu (Targu Mures, RO)

Abstract Slides Video

Presentation thumbnail

Treatment quality in patients with familial hypercholesterolemia in Denmark

Doctor J. Knold (Odense, DK)

Abstract Slides Video

Presentation thumbnail

Suboptimal LDL-C control despite high statin use: insights from the LAI-LCARE survey on secondary CAD prevention in India

Doctor K. Mahajan (Himachal Pradesh, IN)

Abstract Slides Video

Presentation thumbnail

The SLCO1B1 c.521 T > C variant is not associated with muscular symptoms or PCSK9-inhibitor prescription in patients with severe hypercholesterolemia

Doctor L. Galli (Vienna, AT)

Abstract Slides Video

Access the full session

Session thumbnail

Lipids (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Optimizing lipid control after acute coronary syndrome: can we strike early and strong in real-world practice?

Congress Presentation

Impact of a pharmacist-led clinic in optimising lipid therapy for post-acute coronary syndromes (ACS) in high risk cardiovascular patients.

Congress Presentation

Factors influencing low-density-lipoprotein cholesterol after acute coronary syndrome and effectiveness of intensive teleconsultation monitoring, the teleobjectif cohort study

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources